期刊文献+

低T3综合征在急诊重症患者发病率及T3对预后的评估 被引量:9

Clinical significance of low triiodothyronine syndrome in critical patients and triiodothyronine impact on evaluation of prognosis
原文传递
导出
摘要 目的探讨低T3综合征在急诊重症监护病房(EICU)患者中的发病率以及T3水平对急诊危重症患者预后评估价值。方法选择北京顺义区医院EICU2012年10月至2013年4月收治的危重症患者150例,在人院当天以及住院第3天行甲状腺功能检查并在入院当天进行APACHEⅡ评分,将凡是甲状腺功能检查结果符合低T3综合征诊断的患者分为低T3综合征组共计38例;其余112例为非低T3综合征组。计算150例危重症患者中低T3综合征的发生率并且随访至28d,计算各组28d病死率;利用ROC曲线判断T3值水平对危重症患者死亡预后价值。结果150例人选危重症患者中,低T3综合征的发生率约为25.3%;随访28d,低T3综合征组患者病死率为42.1%,非低T3综合征组患者病死率为29.5%;按28d患者预后进行死亡与存活进行分组,利用ROC曲线检测T3水平对危重症患者死亡预后,并且与APACHEⅡ评分进行比较:曲线下面积T3为0.768(95%CI:0.701~0.835),APACHEII为0.783(95%CI:0.719~0.846),两者比较未达到统计学意义;T3最佳死亡预后判断界值为0.41ng/mL,其敏感度为76.6%,特异度为78.4%。结论伴发低T3综合征的EICU危重患者预后差,T3值指标可以作为危重症患者预后的一个参考指标。 Objective To identify the clinical significance of low triiodothyronine syndrome and the potential impact of triiodothyronine (T3 ) on prognosis in critical patients. Methods A total of 150 critically ill patients enrolled from October 2012 to April 2013 were divided into two groups, namely low thyroidhormone group (n =38, group A) and normal T3 group (n = 112, group B). APACHE Ⅱ scores of patients were recorded at admission and thyroid hormone levels were measured on the first and the third day after admission. Then the survival state of 28-day in each group was observed and then the relationship between prognosis and T3 levels was analyzed by receiver operating characteristic (ROC) curve. Results About 25.3% of 150 critical patients were suffered from low thyroidhormone syndrome and the mortality rate in this group was 42. 1% , which was much higher than 29. 5% in normal T3 group. There was no difference in prediction of death rate analyzed by ROC curve between the T3 level and APACHE Ⅱ scores. The area under curve of T3 level was 0. 768 (95% CI: 0. 7014). 835) and APACHE Ⅱ was 0. 783 (95% (3: O. 7194). 846). Best cut-off value of T3 level was 0. 41 ng/mL resulting in 76. 6% sensitivity and78.4% specificity. Conclusions Critically ill patients complicated with low thyroidhormone syndrome has poor prognosis and T3 may be a predictive marker in evaluating the prognosis of critically ill patients.
出处 《中华急诊医学杂志》 CAS CSCD 北大核心 2013年第10期1132-1135,共4页 Chinese Journal of Emergency Medicine
关键词 危重症低T3综合征 预后 ROC曲线 病死率 APACHE Ⅱ评分 重症监护 非甲状腺病态综合征 Critical Low triiodothyronine syndrome Prognosis ROC curves APACHE Ⅱ score Intensive care unit Euthyroid sick syndrome
  • 相关文献

参考文献15

  • 1Docter R, Krenning EP, Jong MD, et al. The sick euthyroidsyndrome: changes in thyroid hormone serum parameters and hormone metabolism [J]. Clin Endocrinol, 1993, 39 (4) : 499- 518. 被引量:1
  • 2Knaus WA, Draper EA, Wagner DP, et al. APACHE 1I: a severity of disease classification system [ J ]. Crit Care Med, 1985, 13 (10): 818-829. 被引量:1
  • 3赵催春,任颖.低T_3综合征与重症疾病[J].上海交通大学学报(医学版),2008,28(8):1042-1044. 被引量:7
  • 4Clee man J. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults [ J ]. JAMA, 2001, 285 (19): 2468-2497. 被引量:1
  • 5Albrecht C, Simon Vermot I, Temothy L, et al. Leukocyte ABCA- gene expression is a associated with fasting glucose concentration in norm-glycemicmen [J]. Metabolism, 2004, 53 (1) : 17-21. 被引量:1
  • 6Meyer S, Schuetz P, Wieland M, et al. Low triiodothyronine syndrome: a prognostic marker for outcome in sepsis? [ J ]. Endocrine, 2011, 39 (2) : 167-174. 被引量:1
  • 7Lee WY, Kang MI, Oh KW, et al. Relationship between circulating cytokine levels and thyroid function following bone marrow transplantation [ J]. Bone Marrow Transplant, 2004, 33 ( 1 ) : 93-98. 被引量:1
  • 8Adler SM, Wartofsky L. The nonthyroidal illness syndrome [ J ]. Endocrinol Metab Clin North Am, 2007, 36 (3) : 657-672. 被引量:1
  • 9Krenn H, Dora C, Fitzgerald RD, et al. Prognostic value of APACHE I[ and m for preoperative evaluation of emergency surgery patients [J]. Eur J Anaesthesiol, 2000, 17 (8) : 529 - 530. 被引量:1
  • 10Warner MH, Beekett GJ. Mechanisms behind the non-thyroidal illness syndrome: an update I J]. Endocrinology, 2010, 205. 被引量:1

二级参考文献40

  • 1姚咏明,盛志勇.重视对脓毒症本质的探讨[J].中华急诊医学杂志,2005,14(3):185-186. 被引量:118
  • 2董宁,姚咏明,金伯泉,刘辉,曹玉珏,贺立新,柴家科,盛志勇.CD14基因多态性与严重烧伤患者预后及人白细胞抗原DR表达的相关性研究[J].中华创伤杂志,2006,22(8):565-569. 被引量:5
  • 3董宁,姚咏明,曹玉珏,贺立新,柴家科,徐姗,盛志勇.严重烧伤患者人白细胞抗原DR定量表达的临床意义[J].中华外科杂志,2007,45(11):766-769. 被引量:9
  • 4Jabre P, Combes X, Lapostolle F, et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial [J]. Lancet, 2009, 374(9686): 293-300. 被引量:1
  • 5Annetta M, Maviglia R, Proietti R, et al. Use of corticosteroids in critically ill septic patients: a review of mechanisms of adrenal insufficiency in sepsis and treatment [J]. Curr Drug Targets, 2009, 10(9): 887- 894. 被引量:1
  • 6Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine [ J ]. Crit Care Mad, 2008, 36(6): 1937-1949. 被引量:1
  • 7Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J]. JAMA, 2002, 288 (7): 862-871. 被引量:1
  • 8Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock [J]. N Engl Med, 2008, 358(2): 111-124. 被引量:1
  • 9Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: Intemational guidelines for management of severe sepsis and septic shock: 2008 [J]. Crit Care Med, 2008, 36(1): 296-327. 被引量:1
  • 10Annane D, Bellissant E, Bollaert PE, et al. Cortieosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review [J]. JAMA, 2009, 301(22): 2362-2375. 被引量:1

共引文献36

同被引文献58

引证文献9

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部